These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23060790)

  • 21. A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Choi YM; Kim H; Lee SA; Lee SY; Kim BJ
    Front Immunol; 2020; 11():652. PubMed ID: 32508804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.
    Margeridon-Thermet S; Shafer RW
    Viruses; 2010 Dec; 2(12):2696-739. PubMed ID: 21243082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Korean medicinal plant extracts exhibit antiviral potency against viral hepatitis.
    Jacob JR; Korba BE; You JE; Tennant BC; Kim YH
    J Altern Complement Med; 2004 Dec; 10(6):1019-26. PubMed ID: 15673997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.
    Chen WC; Wang SY; Chiu CC; Tseng CK; Lin CK; Wang HC; Lee JC
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1180-91. PubMed ID: 23254429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heme oxygenase-1 metabolite biliverdin, not iron, inhibits porcine reproductive and respiratory syndrome virus replication.
    Zhang A; Duan H; Li N; Zhao L; Pu F; Huang B; Wu C; Nan Y; Du T; Mu Y; Zhao Q; Sun Y; Zhang G; Hiscox JA; Zhou EM; Xiao S
    Free Radic Biol Med; 2017 Jan; 102():149-161. PubMed ID: 27908781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome.
    Delaney WE
    Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus.
    Thiers V; Pol S; Persico T; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
    J Viral Hepat; 1998 Mar; 5(2):123-30. PubMed ID: 9572037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection.
    Shankaran P; Vlkova L; Liskova J; Melkova Z
    Antiviral Res; 2011 Dec; 92(3):434-46. PubMed ID: 22001321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    Deng H; Deng X; Liu Y; Xu Y; Lan Y; Gao M; Xu M; Gao H; Wu X; Liao B; Chen W; Zhao M; Hu F; Wang Z
    J Med Virol; 2018 Jul; 90(7):1246-1256. PubMed ID: 29574921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development.
    Hu J; Liu K; Luo J
    Cancer Treat Res; 2019; 177():231-250. PubMed ID: 30523627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.